References
Pharoah PD, Antoniou AC, Easton DF, Ponder BA (2008) Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl J Med 358:2796–2803. doi:10.1056/NEJMsa0708739
Subramanian A, Salhab M, Mokbel K (2008) Oestrogen producing enzymes and mammary carcinogenesis: a review. Breast Cancer Res Treat 111:191–202. doi:10.1007/s10549-007-9788-0
Gonzalez-Zuloeta Ladd AM, Vasquez AA, Rivadeneira F, Siemes C, Hofman A, Stricker BH, Pols HA, Uitterlinden AG, van Duijn CM (2008) Estrogen receptor alpha polymorphisms and postmenopausal breast cancer risk. Breast Cancer Res Treat 107:415–419. doi:10.1007/s10549-007-9562-3
Justenhoven C, Hamann U, Schubert F, Zapatka M, Pierl CB, Rabstein S, Selinski S, Mueller T, Ickstadt K, Gilbert M, Ko YD, Baisch C, Pesch B, Harth V, Bolt HM, Vollmert C, Illig T, Eils R, Dippon J, Brauch H (2008) Breast cancer: a candidate gene approach across the estrogen metabolic pathway. Breast Cancer Res Treat 108:137–149. doi:10.1007/s10549-007-9586-8
Talbott KE, Gammon MD, Kibriya MG, Chen Y, Teitelbaum SL, Long CM, Gurvich I, Santella RM, Ahsan H (2008) A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk. Breast Cancer Res Treat 111:481–487. doi:10.1007/s10549-007-9794-2
Yu K-D, Di G-H, Yuan W-T, Fan L, Wu J, Hu Z, Shen Z-Z, Zheng Y, Huang W, Shao Z-M (2009) Functional polymorphisms, altered gene expression and genetic association link NRH:quinone oxidoreductase 2 to breast cancer with wild-type p53. Hum Mol Genet. doi:10.1093/hmg/ddp171
Wang W, Le WD, Pan T, Stringer JL, Jaiswal AK (2008) Association of NRH:quinone oxidoreductase 2 gene promoter polymorphism with higher gene expression and increased susceptibility to Parkinson’s disease. J Gerontol A Biol Sci Med Sci 63:127–134
Harada S, Fujii C, Hayashi A, Ohkoshi N (2001) An association between idiopathic Parkinson’s disease and polymorphisms of phase II detoxification enzymes: glutathione S-transferase M1 and quinone oxidoreductase 1 and 2. Biochem Biophys Res Commun 288:887–892. doi:10.1006/bbrc.2001.5868
Acknowledgments
This research is supported by grants from the National Basic Research Program of China (2006CB910501), the Shanghai Science and Technology Committee (06DJ14004, 06DZ19504), Shanghai Municipal Natural Science Foundation (07ZR14025) and the Specialized Research Fund for the Doctoral Program of Higher Education (2008–2010).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yu, KD., Di, GH., Fan, L. et al. Caution regarding genotyping methodology for a tri-allelic polymorphism in the novel breast cancer susceptibility gene NQO2. Breast Cancer Res Treat 118, 647–649 (2009). https://doi.org/10.1007/s10549-009-0431-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-009-0431-0